477 research outputs found
e-Research and Jurisdiction
As part of their daily activities, those involved in e-research will often transfer information, including background materials, research results and software, across state and national borders. The act of transferring information across state and national borders raises a number of jurisdictional issues. This chapter will discuss key issues regarding intellectual property, privacy and dispute resolution as they arise from eresearchers transferring information across state and national borders, and how these issues may contractually be resolved
Subcortical Structures in Humans Can Be Facilitated by Transcranial Direct Current Stimulation
Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that alters cortical excitability. Interestingly, in recent animal studies facilitatory effects of tDCS have also been observed on subcortical structures. Here, we sought to provide evidence for the potential of tDCS to facilitate subcortical structures in humans as well. Subjects received anodal-tDCS and sham-tDCS on two separate testing days in a counterbalanced order. After stimulation, we assessed the effect of tDCS on two responses that arise from subcortical structures; (1) wrist and ankle responses to an imperative stimulus combined with a startling acoustic stimulus (SAS), and (2) automatic postural responses to external balance perturbations with and without a concurrent SAS. During all tasks, response onsets were significantly faster following anodal-tDCS compared to sham-tDCS, both in trials with and without a SAS. The effect of tDCS was similar for the dominant and non-dominant leg. The SAS accelerated the onsets of ankle and wrist movements and the responses to backward, but not forward perturbations. The faster onsets of SAS-induced wrist and ankle movements and automatic postural responses following stimulation provide strong evidence that, in humans, subcortical structures - in particular the reticular formation - can be facilitated by tDCS. This effect may be explained by two mechanisms that are not mutually exclusive. First, subcortical facilitation may have resulted from enhanced cortico-reticular drive. Second, the applied current may have directly stimulated the reticular formation. Strengthening reticulospinal output by tDCS may be of interest to neurorehabilitation, as there is evidence for reticulospinal compensation after corticospinal lesions
The evolution of precision oncology:The ongoing impact of the Drug Rediscovery Protocol (DRUP)
Background and purpose: The Drug Rediscovery Protocol (DRUP) is a Dutch, pan-cancer, nonrandomized clinical trial that aims to investigate the efficacy and safety of targeted and immunotherapies outside their registered indication in patients with advanced or metastatic cancer. Patients: Patients with advanced or metastatic cancer are eligible when there are no standard of care treatment options left and the tumor possesses a molecular genomic variant for which commercially available anticancer treatment is accessible off-label in DRUP. Clinical benefit is the study’s primary endpoint, characterized by a confirmed objective response or stable disease after at least 16 weeks of treatment. Results: More than 2,500 patients have undergone evaluation, of which over 1,500 have started treatment in DRUP. The overall clinical benefit rate (CBR) remains 33%. The nivolumab cohort for patients with microsatellite instable metastatic tumors proved highly successful with a CBR of 63%, while palbociclib or ribociclib in patients with tumors harboring CDK4/6 pathway alterations showed limited efficacy, with a CBR of 15%. The formation of two European initiatives (PCM4EU and PRIME-ROSE) strives to accelerate implementation and enhance data collection to broaden equitable access to anticancer treatments and gather more evidence. Conclusion: DRUP persists in improving patients access to off-label targeted or immunotherapy in the Netherlands and beyond. The expansion of DRUP-like clinical trials across Europe provides countless opportunities for broadening the horizon of precision oncology.</p
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer:Results from the drug rediscovery protocol (DRUP)
Background: In 2–5% of patients with colorectal cancer (CRC), human epidermal growth factor 2 (HER2) is amplified or overexpressed. Despite prior evidence that anti-HER2 therapy confers clinical benefit (CB) in one-third of these patients, it is not approved for this indication in Europe. In the Drug Rediscovery Protocol (DRUP), patients are treated with off-label drugs based on their molecular profile. Here, we present the results of the cohort ‘trastuzumab/pertuzumab for treatment-refractory patients with RAS/BRAF-wild-type HER2amplified metastatic CRC (HER2+mCRC)’. Methods: Patients with progressive treatment-refractory RAS/BRAF-wild-type HER2+mCRC with measurable disease were included for trastuzumab plus pertuzumab treatment. Primary endpoints of DRUP are CB (defined as confirmed objective response (OR) or stable disease (SD) ≥ 16 weeks) and safety. Patients were enrolled using a Simon-like 2-stage model, with 8 patients in stage 1 and 24 patients in stage 2 if at least 1/8 patients had CB. To identify biomarkers for response, whole genome sequencing (WGS) was performed on pre-treatment biopsies. Results: CB was observed in 11/24 evaluable patients (46%) with HER2+mCRC, seven patients achieved an OR (29%). Median duration of response was 8.4 months. Patients had undergone a median of 3 prior treatment lines. Median progression-free survival and overall survival were 4.3 months (95% CI 1.9–10.3) and 8.2 months (95% CI 7.2–14.7), respectively. No unexpected toxicities were observed. WGS provided potential explanations for resistance in 3/10 patients without CB, for whom WGS was available. Conclusions: The results of this study confirm a clinically significant benefit of trastuzumab plus pertuzumab treatment in patients with HER2+mCRC.</p
Particle density fluctuations
Event-by-event fluctuations in the multiplicities of charged particles and
photons at SPS energies are discussed. Fluctuations are studied by controlling
the centrality of the reaction and rapidity acceptance of the detectors.
Results are also presented on the event-by-event study of correlations between
the multiplicity of charged particles and photons to search for DCC-like
signals.Comment: Talk presented at Quark Matter 2002, Nantes, Franc
Search for DCC in 158A GeV Pb+Pb Collisions
A detailed analysis of the phase space distributions of charged particles and
photons have been carried out using two independent methods. The results
indicate the presence of nonstatistical fluctuations in localized regions of
phase space.Comment: Talk at the PANIC99 Conference, June 9-16, 199
Central Pb+Pb Collisions at 158 A GeV/c Studied by Pion-Pion Interferometry
Two-particle correlations have been measured for identified negative pions
from central 158 AGeV Pb+Pb collisions and fitted radii of about 7 fm in all
dimensions have been obtained. A multi-dimensional study of the radii as a
function of kT is presented, including a full correction for the resolution
effects of the apparatus. The cross term Rout-long of the standard fit in the
Longitudinally CoMoving System (LCMS) and the vl parameter of the generalised
Yano-Koonin fit are compatible with 0, suggesting that the source undergoes a
boost invariant expansion. The shapes of the correlation functions in Qinv and
Qspace have been analyzed in detail. They are not Gaussian but better
represented by exponentials. As a consequence, fitting Gaussians to these
correlation functions may produce different radii depending on the acceptance
of the experimental setup used for the measurement.Comment: 13 pages including 10 figure
Present Status and Future of DCC Analysis
Disoriented Chiral Condensates (DCC) have been predicted to form in high
energy heavy ion collisions where the approximate chiral symmetry of QCD has
been restored. This leads to large imbalances in the production of charged to
neutral pions. Sophisticated analysis methods are being developed to
disentangle DCC events out of the large background of events with
conventionally produced particles. We present a short review of current
analysis methods and future prospects.Comment: 12 pages, 5 figures. Invited talk presented at the 13th International
Conference on Ultrarelativistic Nucleus-Nucleus Collisions (Quark Matter 97),
Tsukuba, Japan, 1-5 Dec 199
Search for Disoriented Chiral Condensates in 158 AGeV Pb+Pb Collisions
The restoration of chiral symmetry and its subsequent breaking through a
phase transition has been predicted to create regions of Disoriented Chiral
Condensates (DCC). This phenomenon has been predicted to cause anomalous
fluctuations in the relative production of charged and neutral pions in
high-energy hadronic and nuclear collisions. The WA98 experiment has been used
to measure charged and photon multiplicities in the central region of 158 AGeV
Pb+Pb collisions at the CERN SPS. In a sample of 212646 events, no clear DCC
signal can be distinguished. Using a simple DCC model, we have set a 90% C.L.
upper limit on the maximum DCC production allowed by the data.Comment: 20 Pages, LaTeX, uses elsart.cls, 8 eps figures included, submitted
to Physics Letters
Kaon Production and Kaon to Pion Ratio in Au+Au Collisions at \snn=130 GeV
Mid-rapidity transverse mass spectra and multiplicity densities of charged
and neutral kaons are reported for Au+Au collisions at \snn=130 GeV at RHIC.
The spectra are exponential in transverse mass, with an inverse slope of about
280 MeV in central collisions. The multiplicity densities for these particles
scale with the negative hadron pseudo-rapidity density. The charged kaon to
pion ratios are and
for the most central collisions. The ratio is lower than the same
ratio observed at the SPS while the is higher than the SPS result.
Both ratios are enhanced by about 50% relative to p+p and +p
collision data at similar energies.Comment: 6 pages, 3 figures, 1 tabl
- …